Skip to main content

Table 1 Prescription pattern at index date

From: Clinical attributes, treatment, and control in hypertension (CATCH)—a French and Italian longitudinal patient database study

Medication category France Italy
Naive patients (n = 9563) Previously treated patients (n = 138,401) Total (n = 147,964) Naive patients (n = 9027) Previously treated patients (n = 131,162) Total (n = 140,189)
ACEI 988 (10.3 %) 7651 (5.5 %) 8639 (5.8 %) 3438 (38.1 %) 25,593 (19.5 %) 29,031 (20.7 %)
ARB 3132 (32.8 %) 17,937 (13.0 %) 21,069 (14.2 %) 1242 (13.8 %) 13,663 (10.4 %) 14,905 (10.6 %)
Beta blockers 1210 (12.7 %) 12,308 (8.9 %) 13,518 (9.1 %) 1283 (14.2 %) 13,444 (10.2 %) 14,727 (10.5 %)
Centrally acting agents 312 (3.3 %) 1673 (1.2 %) 1985 (1.3 %) 40 (0.4 %) 633 (0.5 %) 673 (0.5 %)
CCB 1238 (12.9 %) 8241 (6.0 %) 9479 (6.4 %) 901 (10.0 %) 15,681 (12.0 %) 16,582 (11.8 %)
Diuretics 902 (9.4 %) 7131 (5.2 %) 8033 (5.4 %) 89 (1.0 %) 312 (0.2 %) 401 (0.3 %)
ACEI + diuretica 291 (3.0 %) 5614 (4.1 %) 5905 (4.0 %) 1026 (11.4 %) 18,420 (14.0 %) 19,446 (13.9 %)
ARB + CCBa 17 (0.2 %) 13 (0.0 %) 30 (0.0 %)
ARB + diuretica 428 (4.5 %) 14,487 (10.5 %) 14,915 (10.1 %) 539 (6.0 %) 14,079 (10.7 %) 14,618 (10.4 %)
Beta blocker + CCBa 10 (0.1 %) 1037 (0.7 %) 1047 (0.7 %) 0 (0.0 %) 3 (0.0 %) 3 (0.0 %)
Beta blocker + diuretica 231 (2.4 %) 3920 (2.8 %) 4151 (2.8 %) 39 (0.4 %) 96 (0.1 %) 135 (0.1 %)
CCB + ACEIa 45 (0.5 %) 766 (0.6 %) 811 (0.5 %)
Free-dose combinationsa 759 (7.9 %) 57,623 (41.6 %) 58,382 (39.5 %) 430 (4.8 %) 29,238 (22.3 %) 29,668 (21.2 %)
  1. ACEI angiotensin-converting enzyme inhibitors, ARB angiotensin II receptor blockers, CCB calcium-channel blockers
  2. aFixed-dose combinations